Biotech and Pharmaceuticals
Omicron subvariants are resistant to key antibody treatments, putting people with weak immune systems at risk of Covid
Emerging omicron subvariants are resistant to key antibody treatments for HIV patients, kidney transplant recipients and other immunocompromised people, making them particularly vulnerable to Covid this winter, the White House warned this week. “With some of the new subvariants that are emerging, some of the main tools we’ve had to protect the immunocompromised like Evusheld […]
Read More
Germany to legalize hashish use for leisure applications
Activists, such as two waving German flags that have a marijuana leaf painted on them, demanding the legalization of cannabis prepare to march in the yearly Hemp Parade (Hanfparade) on August 13, 2016 in Berlin, Germany. Sean Gallup | Getty Pictures News | Getty Images Germany on Wednesday set out strategies to legalize hashish, in […]
Read More
Goldman upgrades Biogen, says it’s poised to address early Alzheimer’s market next year
Biogen shares have a lot more potential upside for investors thanks to positive new data around the company’s early Alzheimer’s drug, Goldman Sachs said Wednesday. The firm upgraded Biogen to a buy from neutral and increased its price target on shares to $370, about 35% from where they closed on Tuesday. The upgrade followed the […]
Read More
More than 100,000 Americans are waiting for an organ transplant
There are more than 100,000 people in the United States waiting for an organ transplant, according to the United Network for Organ Sharing, known as UNOS. “I was born Type 1 diabetic,” said Patrick McGlone, who received a dual kidney-pancreas transplant in June 2021. “There was always the word transplant thrown around. But I never […]
Read More
People who caught mild Covid had increased risk of blood clots, British study finds
A patient receives a coronavirus disease (COVID-19) test at Sparrow Laboratories Drive-Thru Services in Lansing, Michigan, December 27, 2021. Emily Elconin | Reuters People who caught mild cases of Covid-19 during the first year of the pandemic had a higher risk of developing blood clots than those who were not infected, according to a large […]
Read More
Ivermectin — a drug once touted as a Covid treatment by conservatives — doesn’t improve recovery much, clinical trial finds
Ivermectin, a drug once touted by conservatives as a treatment for Covid, does not meaningfully improve the recovery time for people with mild to moderate Covid-19, according a large clinical trial published in a peer-reviewed journal. People who took ivermectin recovered from Covid in 12 days while people who didn’t take the drug recovered in […]
Read More
Jim Cramer says to buy shares of Danaher on the dip
CNBC’s Jim Cramer on Friday advised investors to add Danaher to their shopping lists for next week after it reported third-quarter results. “You’re now getting a chance to buy one of the best-run companies in the world at a big discount. I think you’ve got to take advantage of this pullback [next] Monday morning, because […]
Read More
CDC is discussing using oral polio vaccine for first time in 20 years to stop New York outbreak
The Centers for Disease Control and Prevention is considering using the oral polio vaccine for the first time in more than 20 years to stop an outbreak in the greater New York City metropolitan area that left an adult paralyzed over the summer. “We are in discussions with our New York State and New York […]
Read More
Goldman says buy this under-the-radar biopharma stock expected to rally nearly 80%
This little-known California-based biopharmaceutical stock can see its shares rally nearly 80% in the near term, according to Goldman Sachs. Analyst Paul Choi initiated coverage of Gossamer Bio with a buy rating and a $22 price target, calling attention to upcoming results from the company’s second phase trial of its seralutinib drug as a treatment […]
Read More
Uninsured kids will still receive Covid vaccines for free after shots move to commercial market
A child is administered a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) pediatric vaccine. Mayela Lopez | Reuters The Centers for Disease Control and Prevention took a major step Wednesday toward ensuring that kids who are uninsured can receive Covid-19 vaccines for free after the federal government shifts its immunization program to the commercial market. […]
Read More